Patents by Inventor Karen Annette Duggan

Karen Annette Duggan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nucleic acid quantitation method
    Patent number: 9238831
    Abstract: The present invention relates to methods of quantifying nucleic acids and in particular to an improved universal method of quantifying nucleic acids for gene expression studies without the need for normalising data to a housekeeping gene or to a synthetic gene of interest.
    Type: Grant
    Filed: September 2, 2010
    Date of Patent: January 19, 2016
    Assignee: Accugen Pty Ltd
    Inventors: Karen Annette Duggan, Hong Ha, George Hodge
  • Treatment of kidney fibrosis with VIP fragments
    Patent number: 9238054
    Abstract: The invention relates to compositions comprising vasoactive intestinal peptide (VIP) or fragments thereof, and the use of such compositions in the treatment of kidney disease, in particular kidney fibrosis, and other associated conditions.
    Type: Grant
    Filed: September 24, 2013
    Date of Patent: January 19, 2016
    Assignee: VECTUS BIOSYSTEMS PTY LIMITED
    Inventor: Karen Annette Duggan
  • VIP FRAGMENTS AND METHODS OF USE
    Publication number: 20150065424
    Abstract: The invention relates to composition comprising a pharmaceutically effective amount of one or more functional vasoactive intestinal peptide (VIP) fragments, and the use of those compositions in the treatment of fibrosis, hypertension and other disorder.
    Type: Application
    Filed: November 17, 2014
    Publication date: March 5, 2015
    Applicant: VECTUS BIOSYSTEMS LIMITED
    Inventor: Karen Annette Duggan
  • VIP fragments and methods of use
    Patent number: 8916523
    Abstract: The invention relates to composition comprising a pharmaceutically effective amount of one or more functional vasoactive intestinal peptide (VIP) fragments, and the use of those compositions in the treatment of fibrosis, hypertension and other disorder.
    Type: Grant
    Filed: May 28, 2013
    Date of Patent: December 23, 2014
    Assignee: Vectus Biosystems Limited
    Inventor: Karen Annette Duggan
  • COMPOSITIONS AND METHODS FOR TREATMENT OF AORTIC FIBROSIS
    Publication number: 20140235541
    Abstract: The invention relates to compositions comprising vasoactive intestinal peptide (VIP) or fragments thereof, and the use of such compositions in the treatment of aortic fibrosis and other associated conditions.
    Type: Application
    Filed: April 15, 2014
    Publication date: August 21, 2014
    Applicant: VECTUS BIOSYSTEMS PTY LTD
    Inventor: Karen Annette DUGGAN
  • Methods for the treatment of aortic fibrosis with VIP fragments
    Patent number: 8729020
    Abstract: The invention relates to compositions comprising vasoactive intestinal peptide (VIP) or fragments thereof, and the use of such compositions in the treatment of aortic fibrosis and other associated conditions.
    Type: Grant
    Filed: April 6, 2010
    Date of Patent: May 20, 2014
    Assignee: Vectus Biosystems Pty Ltd
    Inventor: Karen Annette Duggan
  • TREATMENT OF KIDNEY DISORDERS WITH VIP FRAGMENTS
    Publication number: 20140080758
    Abstract: The invention relates to compositions comprising vasoactive intestinal peptide (VIP) or fragments thereof, and the use of such compositions in the treatment of kidney disease, in particular kidney fibrosis, and other associated conditions.
    Type: Application
    Filed: September 24, 2013
    Publication date: March 20, 2014
    Applicant: VECTUS BIOSYSTEMS PTY LIMITED
    Inventor: Karen Annette DUGGAN
  • Treatment of kidney disorders with VIP fragments
    Patent number: 8569235
    Abstract: The invention relates to compositions comprising vasoactive intestinal peptide (VIP) or fragments thereof, and the use of such compositions in the treatment of kidney disease, in particular kidney fibrosis, and other associated conditions.
    Type: Grant
    Filed: October 16, 2009
    Date of Patent: October 29, 2013
    Assignee: Vectus Biosystems Pty Limited
    Inventor: Karen Annette Duggan
  • VIP FRAGMENTS AND METHODS OF USE
    Publication number: 20130244934
    Abstract: The invention relates to composition comprising a pharmaceutically effective amount of one or more functional vasoactive intestinal peptide (VIP) fragments, and the use of those compositions in the treatment of fibrosis, hypertension and other disorder.
    Type: Application
    Filed: May 28, 2013
    Publication date: September 19, 2013
    Applicant: Vectus Biosystems Limited
    Inventor: Karen Annette Duggan
  • VIP fragments and methods of use
    Patent number: 8470778
    Abstract: The invention relates to composition comprising a pharmaceutically effective amount of one or more functional vasoactive intestinal peptide (VIP) fragments, and the use of those compositions in the treatment of fibrosis, hypertension and other disorders.
    Type: Grant
    Filed: December 8, 2006
    Date of Patent: June 25, 2013
    Assignee: Vectus Biosystems Limited
    Inventor: Karen Annette Duggan
  • NUCLEIC ACID QUANTITATION METHOD
    Publication number: 20120231465
    Abstract: The present invention relates to methods of quantifying nucleic acids and in particular to an improved universal method of quantifying nucleic acids for gene expression studies without the need for normalising data to a housekeeping gene or to a synthetic gene of interest.
    Type: Application
    Filed: September 2, 2010
    Publication date: September 13, 2012
    Inventors: Karen Annette Duggan, Hong Ha, George Hodge
  • Compositions and Methods for Treatment of Aortic Fibrosis
    Publication number: 20120027850
    Abstract: The invention relates to compositions comprising vasoactive intestinal peptide (VIP) or fragments thereof, and the use of such compositions in the treatment of aortic fibrosis and other associated conditions.
    Type: Application
    Filed: April 6, 2010
    Publication date: February 2, 2012
    Applicant: VECTUS BIOSYSTEMS PTY LTD
    Inventor: Karen Annette Duggan
  • COMPOSITIONS AND METHODS FOR TREATMENT OF KIDNEY DISORDERS
    Publication number: 20110218149
    Abstract: The invention relates to compositions comprising vasoactive intestinal peptide (VIP) or fragments thereof, and the use of such compositions in the treatment of kidney disease, in particular kidney fibrosis, and other associated conditions.
    Type: Application
    Filed: October 16, 2009
    Publication date: September 8, 2011
    Applicant: VECTUS BIOSYSTEMS PTY LIMITED
    Inventor: Karen Annette Duggan
  • Vip Fragments and Methods of Use
    Publication number: 20090005315
    Abstract: The invention relates to composition comprising a pharmaceutically effective amount of one or more functional vasoactive intestinal peptide (VIP) fragments, and the use of those compositions in the treatment of fibrosis, hypertension and other disorders.
    Type: Application
    Filed: December 8, 2006
    Publication date: January 1, 2009
    Applicant: VECTUS BIOSYSTEMS LIMITED
    Inventor: Karen Annette Duggan